While this trial showed trends toward fat loss in the treatment groups, the primary endpoint of statistically significant weight reduction compared to placebo was not consistently achieved across all dose groups, and effect sizes were more modest than hoped
If nausea persists beyond 3-4 weeks on a stable dose, consider reducing to the previous dose level and attempting re-escalation more gradually after 4-6 weeks
BPC-157 focuses on localized tissue repair , while TB-500 enhances systemic healing and cell migration
FAQs about Complete AOD-9604 Dosage Chart What is the typical AOD-9604 dosage
The FDA has issued advisories to caution against the compounding of and use of this substance
Schedule a consultation with Florida Surgery & Weight Loss Center to discuss your recovery goals, wellness objectives, and whether BPC-157 peptide therapy may be appropriate for you